Cary Street Partners Investment Advisory LLC Abb Vie Inc. Transaction History

Cary Street Partners Investment Advisory LLC

$2.63 Billion
Q3 2024

A detailed history of Cary Street Partners Investment Advisory LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Cary Street Partners Investment Advisory LLC holds 129,870 shares of ABBV stock, worth $23.4 Million. This represents 0.97% of its overall portfolio holdings.

Number of Shares

129,870

Previous 125,918 3.14%

Holding current value

$23.4 Million

Previous $21.6 Million 18.75%

% of portfolio

0.97%

Previous 0.89%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 30, 2024	BUY	$163.84 - $199.33 $647,495 - $787,752	3,952 Added 3.14%	129,870 $25.6 Million
Q2 2024 Jul 22, 2024	BUY	$154.79 - $180.76 $591,607 - $690,864	3,822 Added 3.13%	125,918 $21.6 Million
Q1 2024 Apr 30, 2024	BUY	$159.82 - $182.1 $273,611 - $311,755	1,712 Added 1.42%	122,096 $22.2 Million
Q4 2023 Feb 07, 2024	BUY	$137.6 - $154.97 $14.2 Million - $16 Million	103,003 Added 592.62%	120,384 $18.7 Million
Q4 2023 Feb 05, 2024	SELL	$137.6 - $154.97 $13.9 Million - $15.7 Million	-101,073 Reduced 85.33%	17,381 $2.69 Million
Q3 2023 Nov 13, 2023	BUY	$133.59 - $154.65 $3.45 Million - $3.99 Million	25,813 Added 27.86%	118,454 $17.7 Million
Q2 2023 Aug 10, 2023	BUY	$132.51 - $164.9 $203,932 - $253,781	1,539 Added 1.69%	92,641 $12.5 Million
Q1 2023 May 12, 2023	SELL	$144.61 - $166.54 $18,365 - $21,150	-127 Reduced 0.14%	91,102 $14.5 Million
Q4 2022 Feb 14, 2023	SELL	$138.31 - $165.87 $289,206 - $346,834	-2,091 Reduced 2.24%	91,229 $14.8 Million
Q3 2022 Nov 14, 2022	BUY	$134.21 - $153.93 $955,977 - $1.1 Million	7,123 Added 8.26%	93,320 $12.5 Million
Q2 2022 Aug 15, 2022	BUY	$137.62 - $174.96 $9.67 Million - $12.3 Million	70,250 Added 440.52%	86,197 $13.2 Million
Q1 2022 May 16, 2022	SELL	$131.98 - $163.75 $189,259 - $234,817	-1,434 Reduced 8.25%	15,947 $2.59 Million
Q4 2021 Feb 14, 2022	BUY	$107.43 - $135.93 $443,793 - $561,526	4,131 Added 31.18%	17,381 $2.35 Million
Q3 2021 Nov 15, 2021	SELL	$106.4 - $120.78 $26,387 - $29,953	-248 Reduced 1.84%	13,250 $1.43 Million
Q2 2021 Aug 16, 2021	BUY	$105.21 - $117.21 $600,749 - $669,269	5,710 Added 73.32%	13,498 $1.52 Million
Q1 2021 May 17, 2021	SELL	$102.3 - $112.62 $1.33 Million - $1.46 Million	-12,972 Reduced 62.49%	7,788 $843,000
Q4 2020 Feb 12, 2021	SELL	$80.49 - $108.67 $3.8 Million - $5.13 Million	-47,184 Reduced 69.45%	20,760 $2.22 Million
Q3 2020 Nov 12, 2020	BUY	$85.91 - $100.83 $5.51 Million - $6.47 Million	64,174 Added 1702.23%	67,944 $5.95 Million
Q2 2020 Aug 05, 2020	BUY	$73.37 - $98.18 $30,155 - $40,351	411 Added 12.24%	3,770 $370,000
Q1 2020 Apr 21, 2020	BUY	$64.5 - $97.79 $21,672 - $32,857	336 Added 11.11%	3,359 $255,000
Q4 2019 Feb 10, 2020	SELL	$72.13 - $90.25 $721 - $902	-10 Reduced 0.33%	3,023 $268,000
Q4 2018 Feb 06, 2019	BUY	$77.85 - $96.01 $236,119 - $291,198	3,033 New	3,033 $279,000

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cary Street Partners Investment Advisory LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cary Street Partners Investment Advisory LLC with notifications on news.

Account

Cary Street Partners Investment Advisory LLC Abb Vie Inc. Transaction History